# Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions

> **NCT04867603** · — · COMPLETED · sponsor: **Norbert Avril, M.D.** · enrollment: 16 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** [Ga-68]PSMA
- **DEVICE:** PET/CT imaging

## Key facts

- **NCT ID:** NCT04867603
- **Lead sponsor:** Norbert Avril, M.D.
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-06-29
- **Primary completion:** 2022-10-03
- **Final completion:** 2022-10-03
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2023-12-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04867603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04867603, "Digital PET/CT Using [Ga-68]PSMA for Characterization of Prostate Lesions". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04867603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*